In 10 patients who had characterized cfDNA alterations and did not have tissue DNA NGS performed, potential CH‐type mutations were observed in seven patients (70%) (MET amplification and alterations in BRAF, BRCA1, FBXW7, and NF1 were not considered as CH) (Table S3). This evidence concerns the gene NF1 and cyclic hematopoiesis.